No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
300452 Anhui Sunhere Pharmaceutical Excipients
- 11.60
- 0.000.00%
Market Closed Mar 11 15:00 CST
2.72BMarket Cap16.96P/E (TTM)
11.61High11.44Low22.78KlotVolume11.55Open11.60Pre Close26.20MTurnover1.22%Turnover Ratio16.84P/E (Static)234.45MShares15.4052wk High3.11P/B2.17BFloat Cap10.1052wk Low13.92Limit Up186.80MShs Float27.30Historical High9.28Limit Down1.47%Amplitude2.19Historical Low0.25Dividend TTM11.50Avg Price12.72KlotAsk2.16%Div YieldTTM100Lot Size9.48KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Anhui Sunhere Pharmaceutical Excipients: Shareholder FOSUN PHARMA plans to reduce its shareholding by no more than 3% of the company's shares.
Anhui Sunhere Pharmaceutical Excipients (300452.SZ): plans to use part of the raised funds and its own funds to increase capital for its wholly-owned subsidiary to implement fundraising investment projects.
Gelonghui, January 9th - Anhui Sunhere Pharmaceutical Excipients (300452.SZ) announced that it plans to use part of the raised funds and its own funds to increase capital by 92 million yuan to its wholly-owned subsidiary Hefei Sunhere Pharmaceutical Technology Co., Ltd. (referred to as "Hefei Sunhere") for the implementation of the "Hefei R&D Center and Production Base Project", of which 60 million yuan will be from raised funds and 32 million yuan from its own funds. After this capital increase is completed, Hefei Sunhere's registered capital will increase to 100 million yuan, and the company will still Hold 100% of its equity.
Express News | Anhui Sunhere Pharmaceutical Excipients: Wholly-owned subsidiary Hefei Sunhere successfully acquired land use rights.
Anhui Sunhere Pharmaceutical Excipients (300452.SZ): Hefei Sunhere plans to participate in the auction for the land use rights of the TC4-3-2 plot in Hefei High-tech Zone.
On December 10, Gelonghui reported that Anhui Sunhere Pharmaceutical Excipients (300452.SZ) announced that in order to smoothly advance the investment and construction of the project, Hefei Sunhere plans to participate in the auction for the land use rights of the TC4-3-2 plot in the High-tech Zone of Hefei City, Anhui Province. The area of the plot is 19.5824 acres, and the land purchase cost is not less than 5.0130944 million yuan (the specific price is subject to the Fill Price set by the land department).
Yamakawa Yakusuke: Report for the third quarter of 2024
Anhui Sunhere Pharmaceutical Excipients (300452.SZ) released its performance for the first three quarters, with a net income of 0.122 billion yuan, a decrease of 0.89%.
Anhui Sunhere Pharmaceutical Excipients (300452.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...